You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Flipo R, Maillefert J, Chazerain P, et al
Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study
RMD Open 2017;3:e000340. doi: 10.1136/rmdopen-2016-000340